REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 17
- Part 17: For the preceding part double click ID:nRSH4027Rp
regulatory and political pressuresWe face continued economic, regulatory
and political pressures to limit or reduce the cost of our products. In
2010, the US enacted the ACA, a comprehensive health reform law that
expands insurance coverage, implements delivery system reforms and places
a renewed focus on cost and quality. In terms of specific provisions
impacting our industry, the law mandates higher rebates and discounts on
branded drugs for certain Medicare and Medicaid patients as well as an
industry-wide excise fee. Implementation of several health system
delivery reforms included in the ACA has commenced and will continue
through 2018. The ACA expands the patient population eligible for
Medicaid and provides new insurance coverage for individuals through
- More to follow, for following part double click ID:nRSH4027RrRecent news on AstraZeneca
See all newsREG - AstraZeneca PLC - Tozorakimab met OBERON/TITANIA primary endpoints
AnnouncementREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementRCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
Announcement